About Interpharma Group
It operates as a B2B and B2C. Interpharma Group offers products and services including Pharmaceuticals and Animal Health Products.
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website interpharma.co.th
- Social Facebook YouTube
- Legal Name Inter Pharma Public Company Limited
- Annual Revenue$69.14 M (USD)15.61as on Dec 31, 2025
- Net Profit$3.86 M (USD)233.93as on Dec 31, 2025
- EBITDA$9.1 M (USD)67.36as on Dec 31, 2025
Associated legal entities of Interpharma Group
Interpharma Group operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Interpharma Group
Interpharma Group offers a comprehensive portfolio of products and services, including Pharmaceuticals and Animal Health Products.
Medicines and supplements are developed and distributed for human health using advanced technology.
Vaccines and nutritional products are provided for animal care to ensure safety and efficacy.
Apps and channels of Interpharma Group
its YouTube channel Interpharma Thailand has 8.37K subscribers and 30 videos.
Videos from Interpharma Group
The most watched videos on Interpharma Group's YouTube channel, Interpharma Thailand (8.37K subscribers). Click a video to play it here.
More on Interpharma Thailand.
IPO & Listings of Interpharma Group
Interpharma Group is a publicly listed company on the SET with ticker symbol IP in Thailand, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Nov 2019
- Listed onSET: IP
- Listed entityInter Pharma Public Company Limited
- Exchange sectorHealth technology
- ISINTH9474010005
- Share price4.96 THB (+0.81% on the day) · 2026-10-09
- Market capitalisation2,978,294,900.00 THB
- Price to earnings21.8
- EPS (diluted, trailing year)0.23 THB
- Dividend yield1.48%
- Volume (last session)76,220
Financials of Interpharma Group
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 2.19B THB | 122.4M THB | 288.1M THB |
| 2024 | 1.90B THB | 36.6M THB | 172.2M THB |
| 2023 | 1.78B THB | 50.8M THB | 190.1M THB |
| 2022 | 1.52B THB | 118.9M THB | 225.4M THB |
| 2021 | 908.6M THB | 105.2M THB | 160.0M THB |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for Interpharma Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Interpharma Group
Websites that share an audience with Interpharma Group (interpharma.co.th).
Websites whose visitors overlap most with Interpharma Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| zeekdoc.com | 87% | 39K | #786,689 | View details | |
| hd.co.th | 71% | 361.3K | #126,911 | View details |
Latest news on Interpharma Group
Complete news archive for Interpharma Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Interpharma Group
10 companies that operate in the same segment as Interpharma Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Interpharma Group
Annual revenue of Interpharma Group is $69.14M as on Dec 31, 2025.
Interpharma Group is known for its dedication to providing efficient health care solutions for humans and animals. Advanced technologies and innovative manufacturing processes are employed to produce high-quality pharmaceuticals, nutraceuticals, and veterinary products that emphasize safety and value. Operations are conducted across multiple sites in Thailand, where products like medicines, supplements, and vaccines are developed to promote longevity and disease prevention. The companys efforts are aimed at enhancing well-being through reliable and effective offerings, with a focus on both human and animal health sectors.
Interpharma Group offers Pharmaceuticals and Animal Health Products.
Yes, Interpharma Group is publicly traded on SET under the ticker symbol IP.
Interpharma Group operates through ,.